Literature DB >> 15872021

Mutant SOD1 alters the motor neuronal transcriptome: implications for familial ALS.

Janine Kirby1, Eugene Halligan, Melisa J Baptista, Simon Allen, Paul R Heath, Hazel Holden, Sian C Barber, Catherine A Loynes, Clare A Wood-Allum, Joseph Lunec, Pamela J Shaw.   

Abstract

Familial amyotrophic lateral sclerosis (FALS) is caused, in 20% of cases, by mutations in the Cu/Zn superoxide dismutase gene (SOD1). Although motor neuron injury occurs through a toxic gain of function, the precise mechanism(s) remains unclear. Using an established NSC34 cellular model for SOD1-associated FALS, we investigated the effects of mutant SOD1 specifically in cells modelling the vulnerable cell population, the motor neurons, without contamination from non-neuronal cells present in CNS. Using gene expression profiling, 268 transcripts were differentially expressed in the presence of mutant human G93A SOD1. Of these, 197 were decreased, demonstrating that the presence of mutant SOD1 leads to a marked degree of transcriptional repression. Amongst these were a group of antioxidant response element (ARE) genes encoding phase II detoxifying enzymes and antioxidant response proteins (so-called 'programmed cell life' genes), the expression of which is regulated by the transcription factor NRF2. We provide evidence that dysregulation of Nrf2 and the ARE, coupled with reduced pentose phosphate pathway activity and decreased generation of NADPH, represent significant and hitherto unrecognized components of the toxic gain of function of mutant SOD1. Other genes of interest significantly altered in the presence of mutant SOD1 include several previously implicated in neurodegeneration, as well as genes involved in protein degradation, the immune response, cell death/survival and the heat shock response. Preliminary studies on isolated motor neurons from SOD1-associated motor neuron disease cases suggest key genes are also differently expressed in the human disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15872021     DOI: 10.1093/brain/awh503

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  73 in total

Review 1.  Redox proteomics in some age-related neurodegenerative disorders or models thereof.

Authors:  D Allan Butterfield; Hafiz Mohmmad Abdul; Shelley Newman; Tanea Reed
Journal:  NeuroRx       Date:  2006-07

2.  A screen to identify cellular modulators of soluble levels of an amyotrophic lateral sclerosis (ALS)-causing mutant SOD1.

Authors:  Balajee R Somalinga; Gregory A Miller; Hiba T Malik; W Christian Wigley; Philip J Thomas
Journal:  J Biomol Screen       Date:  2011-08-29

Review 3.  The biology of proteostasis in aging and disease.

Authors:  Johnathan Labbadia; Richard I Morimoto
Journal:  Annu Rev Biochem       Date:  2015-03-12       Impact factor: 23.643

4.  MTOR-independent, autophagic enhancer trehalose prolongs motor neuron survival and ameliorates the autophagic flux defect in a mouse model of amyotrophic lateral sclerosis.

Authors:  Xiaojie Zhang; Sheng Chen; Lin Song; Yu Tang; Yufei Shen; Li Jia; Weidong Le
Journal:  Autophagy       Date:  2014-01-15       Impact factor: 16.016

Review 5.  Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis.

Authors:  Laura Ferraiuolo; Janine Kirby; Andrew J Grierson; Michael Sendtner; Pamela J Shaw
Journal:  Nat Rev Neurol       Date:  2011-11       Impact factor: 42.937

Review 6.  Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers.

Authors:  Paul C Trippier; Kristin Jansen Labby; Dustin D Hawker; Jan J Mataka; Richard B Silverman
Journal:  J Med Chem       Date:  2013-03-27       Impact factor: 7.446

7.  Changes in the spinal cord proteome of an amyotrophic lateral sclerosis murine model determined by differential in-gel electrophoresis.

Authors:  Daniel Bergemalm; Karin Forsberg; P Andreas Jonsson; Karin S Graffmo; Thomas Brännström; Peter M Andersen; Henrik Antti; Stefan L Marklund
Journal:  Mol Cell Proteomics       Date:  2009-04-08       Impact factor: 5.911

8.  Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis.

Authors:  Claudia Pitzer; Carola Krüger; Christian Plaas; Friederike Kirsch; Tanjew Dittgen; Ralph Müller; Rico Laage; Stefan Kastner; Stefanie Suess; Robert Spoelgen; Alexandre Henriques; Hannelore Ehrenreich; Wolf-Rüdiger Schäbitz; Alfred Bach; Armin Schneider
Journal:  Brain       Date:  2008-10-03       Impact factor: 13.501

9.  An in vitro screening cascade to identify neuroprotective antioxidants in ALS.

Authors:  Siân C Barber; Adrian Higginbottom; Richard J Mead; Stuart Barber; Pamela J Shaw
Journal:  Free Radic Biol Med       Date:  2009-01-30       Impact factor: 7.376

10.  Progranulin is expressed within motor neurons and promotes neuronal cell survival.

Authors:  Cara L Ryan; David C Baranowski; Babykumari P Chitramuthu; Suneil Malik; Zhi Li; Mingju Cao; Sandra Minotti; Heather D Durham; Denis G Kay; Christopher A Shaw; Hugh P J Bennett; Andrew Bateman
Journal:  BMC Neurosci       Date:  2009-10-27       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.